They wont do it unless they intend to uplist soon or need serious funding. Both are not in the plan in the near ter. They already reach agreement with their creditors for equity funding and along with license agrements and their agency sales will provide them three sources of funding their operations.
I wouldn't think a reverse split would be likely, one reason is because the insiders own so many shares. Mr. Cadwell for example, would not be happy if the number of shares he owned, were divided by a factor of, let's say, 5, or 10. Even though in the previous example the price would increase by a factor of 5, or 10, reverse splits have inherent risks. A reverse split is not a good option in the case of ADMD and shouldn't be considered at this stage. MDLAND~
Not now with the number of shares still available. RS is actually stupid even if FDA came back with a flat out "No". As compared to so many micros out there they did not put that many more shares on the market yr/yr in my opinion and that was without the FDA on the line. Where did this guy come from with all these big market calls for ADMD? Team Ignore alias number 15 or so?